← Back to Clinical Trials
Recruiting NCT03604627

Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Childhood Cancer
Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Study Type INTERVENTIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2018-06-14
Completion 2028-09
Interventions
Coronal calcium score measurement

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To measure coronary calcium score in adults treated during childhood or adolescence for irradiation cancer in the heart and / or anthracycline area and compare them to determine whether irradiation of the heart area is associated with increased calcium score after adjustment for other cardiovascular risk factors (age, sex, smoking, dyslipidemia, obesity, diabetes, high blood pressure and renal failure).

Eligibility Criteria

Inclusion Criteria: 1. Patients 18 years of age or older, 2. Treated for cancer during childhood, adolescence or young adulthood (≤25 years), 3. Treated with irradiation of the heart area (≥20% of ≥5Gy heart rate) and / or anthracycline (cumulative dose of doxorubicin equivalent ≥300mg/m\^²), 4. In complete remission of their pediatric cancer for at least 10 years, 5. Patient affiliated to a social security scheme or beneficiary of such a scheme, 6. Patient Information and Signed Informed Consent. Exclusion Criteria: 1. Perspective less than 10 years, 2. Persons deprived of liberty or guardianship (including trusteeship), 3. Impossibility of submitting to the medical follow-up of the test for geographical, social or psychological reasons, 4. Pregnant women. Inclusion criteria for extension cohort: 1. Patients 30 years of age or older, 2. Treated for cancer during childhood, adolescence or young adulthood (≤25 years), 3. Treated with irradiation of the heart area (≥20% of ≥5Gy heart rat

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}